Atrys Health Stock Forecast

Stock Price Forecast

According to 3 analysts polled by S&P Global, Atrys Health stock has a consensus rating of "Strong Buy" and an average price target of €4.83. The average 1-year stock price forecast is 74.68% higher than the current stock price, while the lowest is €4.00 (+44.67%) and the highest is €5.50 (+98.92%).

Price Target: €4.83 (+74.68%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	€4.00	€4.83	€5.00	€5.50
Change	+44.67%	+74.68%	+80.83%	+98.92%

* Price targets were last updated on Apr 13, 2026.

Analyst Ratings

The average analyst rating for Atrys Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Nov '25	Jan '26	Mar '26	Apr '26	May '26
Strong Buy	3	3	4	3	3	3
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	4	3	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Julian Megias Kepler Capital	Kepler Capital	Buy Maintains €5.00	Buy	Maintains	€5.00	+80.83%	Apr 13, 2026

Financial Forecast

Revenue This Year

156.20M

from 144.31M

8.24%

from 144.31M

Revenue Next Year

168.58M

from 156.20M

7.93%

from 156.20M

EPS This Year

0.06

from -0.22

EPS Next Year

0.15

from 0.06

166.07%

from 0.06

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	123.85M	163.20M	206.10M	134.88M	144.31M	156.20M
Revenue Growth	266.34%	31.77%	26.28%	-34.56%	7.00%	8.24%
Gross Profit	34.19M	46.95M	57.15M	30.34M	24.92M	69.20M
Gross Margin	27.60%	28.77%	27.73%	22.50%	17.27%	44.30%
Operating Income	-4.03M	-10.75M	-1.58M	-162.00K	-10.40M	732.24K
Net Income	-23.26M	-23.15M	-45.59M	-31.77M	-100.30M	782.50K
EPS	-	-	-	-	-0.22	0.06
Forward PE	36.01	29.58	25.81	156.74	-	47.82
Free Cash Flow	-5.09M	21.48M	-28.29M	-7.19M	-129.51M	172.00M
No. Analysts	-	-	-	-	-	3

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.

Revenue Forecast

Revenue	2026	2027	2028
High	159.2M
Avg	156.2M
Low	153.4M

Revenue Growth

Revenue Growth	2026	2027	2028
High	10.3%
Avg	8.2%
Low	6.3%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	0.06
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-